(Q70539221)
Statements
A phase II trial of Didemnin B (NSC #335319) in patients with previously treated epithelial ovarian cancer. A Gynecologic Oncology Group Study (English)
J H Malfetano
J A Blessing
1 February 1993
scientific article published on 01 February 1993